Glaxosmithkline Plc Adr Stock Technical Analysis

GSK Stock  USD 42.87  0.12  0.28%   
As of the 29th of March, GlaxoSmithKline PLC retains the risk adjusted performance of 0.1457, and Market Risk Adjusted Performance of 1.72. GlaxoSmithKline PLC technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We are able to interpolate and collect nineteen technical drivers for GlaxoSmithKline PLC ADR, which can be compared to its competitors. Please check out GlaxoSmithKline PLC ADR coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if GlaxoSmithKline PLC is priced fairly, providing market reflects its last-minute price of 42.87 per share. Given that GlaxoSmithKline PLC ADR has jensen alpha of 0.216, we strongly advise you to confirm GlaxoSmithKline PLC ADR's regular market performance to make sure the company can sustain itself at a future point.

GlaxoSmithKline PLC Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as GlaxoSmithKline, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GlaxoSmithKline
  
GlaxoSmithKline PLC's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

GlaxoSmithKline PLC Analyst Consensus

Target PriceAdvice# of Analysts
39.63Buy8Odds
GlaxoSmithKline PLC ADR current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most GlaxoSmithKline analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand GlaxoSmithKline stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of GlaxoSmithKline PLC ADR, talking to its executives and customers, or listening to GlaxoSmithKline conference calls.
GlaxoSmithKline Analyst Advice Details
GlaxoSmithKline PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of GlaxoSmithKline PLC technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of GlaxoSmithKline PLC trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

GlaxoSmithKline PLC ADR Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of GlaxoSmithKline PLC ADR volatility. High ATR values indicate high volatility, and low values indicate low volatility.

GlaxoSmithKline PLC ADR Trend Analysis

Use this graph to draw trend lines for GlaxoSmithKline PLC ADR. You can use it to identify possible trend reversals for GlaxoSmithKline PLC as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual GlaxoSmithKline PLC price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

GlaxoSmithKline PLC Best Fit Change Line

The following chart estimates an ordinary least squares regression model for GlaxoSmithKline PLC ADR applied against its price change over selected period. The best fit line has a slop of   0.09  , which may imply that GlaxoSmithKline PLC ADR will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 277.36, which is the sum of squared deviations for the predicted GlaxoSmithKline PLC price change compared to its average price change.

About GlaxoSmithKline PLC Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of GlaxoSmithKline PLC ADR on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of GlaxoSmithKline PLC ADR based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on GlaxoSmithKline PLC ADR price pattern first instead of the macroeconomic environment surrounding GlaxoSmithKline PLC ADR. By analyzing GlaxoSmithKline PLC's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of GlaxoSmithKline PLC's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to GlaxoSmithKline PLC specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 (projected)
Price Earnings Ratio14.9111.9223.96
Short Term Coverage Ratios2.211.872.26

GlaxoSmithKline PLC March 29, 2024 Technical Indicators

Most technical analysis of GlaxoSmithKline help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for GlaxoSmithKline from various momentum indicators to cycle indicators. When you analyze GlaxoSmithKline charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

GlaxoSmithKline PLC March 29, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as GlaxoSmithKline stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
0.58
Earnings Share
3.03
Revenue Per Share
14.97
Quarterly Revenue Growth
0.092
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.